Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid route comparison in humerus fracture surgery
IRCT20141209020258N184Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in humerus fracture (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Bleeding. Started Jun 2023; status: completed.
02
Drugs
tranexamic acid
03
Conditions
humerus fracture
Beyond the preview
Go deeper on IRCT20141209020258N184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N184.